Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Divergent trajectories of antiviral memory after SARS-CoV-2 infection

Journal article

Tomic A. et al, (2022), Nature Communications, 13

Presentations at the UK National Immunisation Conference.

Journal article

Pollard AJ. et al, (2022), Human vaccines & immunotherapeutics

Febrile illness in high-risk children: a prospective, international observational study.

Journal article

van der Velden FJS. et al, (2022), European journal of pediatrics

Detection of poliovirus in London highlights the value of sewage surveillance.

Journal article

Hill M. and Pollard AJ., (2022), Lancet (London, England)

Effect of the of 10-valent pneumococcal conjugate vaccine in Nepal 4 years after introduction: an observational cohort study

Journal article

Shrestha S. et al, (2022), The Lancet Global Health, 10, e1494 - e1504

Variation in CFHR3 determines susceptibility to meningococcal disease by controlling factor H concentrations.

Journal article

Kumar V. et al, (2022), American journal of human genetics

Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme.

Journal article

Carr JP. et al, (2022), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Addressing vaccine inequities among Ukrainian refugees.

Journal article

Hill M. et al, (2022), Lancet Infect Dis, 22, 935 - 936

An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females

Journal article

Marchevsky NG. et al, (2022), eBioMedicine, 81, 104128 - 104128

Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.

Journal article

Tuekprakhon A. et al, (2022), Cell, 185, 2422 - 2433.e13

Year-to-year variation in attack rates could result in underpowered respiratory syncytial virus vaccine efficacy trials

Journal article

Billard MN. et al, (2022), Journal of Clinical Epidemiology, 147, 11 - 20

Potent cross-reactive antibodies following Omicron breakthrough in vaccinees.

Journal article

Nutalai R. et al, (2022), Cell, 185, 2116 - 2131.e18

Viral vector vaccines.

Journal article

McCann N. et al, (2022), Current opinion in immunology, 77

Future reporting of vaccine uptake needs to include any change in ethnic or socioeconomic disparities.

Journal article

Hoang U. et al, (2022), BMJ (Clinical research ed.), 377

Adenovirus vectors activate Vδ2 + γδT cells in a type I interferon‐, TNF‐, and IL‐18‐dependent manner

Journal article

Provine NM. et al, (2022), European Journal of Immunology, 52, 835 - 837

Innovative vaccine approaches-a Keystone Symposia report.

Journal article

Cable J. et al, (2022), Annals of the New York Academy of Sciences, 1511, 59 - 86

Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

Journal article

Ogbe A. et al, (2022), JCI Insight, 7

Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCR.

Journal article

Ratcliff J. et al, (2022), Journal of clinical microbiology

Genetic Susceptibility to Enteric Fever in Experimentally Challenged Human Volunteers.

Journal article

Barton A. et al, (2022), Infection and immunity

Public engagement during a typhoid conjugate vaccine trial in Lalitpur, Nepal- experience, challenges and lessons learnt.

Journal article

Dahal A. et al, (2022), Human vaccines & immunotherapeutics, 1 - 5

A blood atlas of COVID-19 defines hallmarks of disease severity and specificity

Journal article

Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58

Decoupling of omicron variant infections and severe COVID-19.

Journal article

Madhi SA. et al, (2022), Lancet (London, England), 399, 1047 - 1048

SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses

Journal article

Dejnirattisai W. et al, (2022), Cell, 185, 467 - 484.e15

COVID-19 vaccine strategies must focus on severe disease and global equity.

Journal article

McIntyre PB. et al, (2022), Lancet (London, England), 399, 406 - 410

Childhood Invasive Bacterial Disease in Kathmandu, Nepal (2005-2013).

Journal article

Carter MJ. et al, (2021), The Pediatric infectious disease journal

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.

Journal article

Dejnirattisai W. et al, (2021), Lancet (London, England)

Load More